CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Study of c-Src gene expression in response to an anti-angiogenesis peptide in breast cancer mice

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 56
Year: 2018
COI code: CIGS15_067
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Study of c-Src gene expression in response to an anti-angiogenesis peptide in breast cancer mice

  Maedeh Bejary - Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran
  Soheila Talesh Sasani - Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran
  S Mohsen Asghari - Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran

Abstract:

Breast cancer is the main cause of cancer death in women. Human pp60c-Src (or c-Src) is a 60 kDa non-receptor tyrosine kinase encoded by the Rous sarcoma gene (Src). C-Src functions in several signal transduction cascades that affect cellular proliferation, motility, differentiation, survival and regulate blood vessels growth. Tyrosine phosphorylation of VEGF receptor1 (VEGFR1) facilitates binding to the Src homologue domain. Inhibition of vascular endothelial growth factor (VEGF) binding to its receptor increases the efficiency of chemotherapy. In this study we will assess c-Src expression level in Balb/c mice (pasteur institute, Iran) having 4T1 cell-line induced and were treated with a VEGFB antagonist peptide. Breast tissue samples were obtained from treated and untreated mice (as control). Total RNA was isolated using Trizol reagent(Invitrogen) followed by cDNA synthesis. Real time polymerase chain reaction was carried out using c-Src specific primers and relative expression of c-Src gene was assessed. We used U6 gene as the reference. Our results showed the expression level of c-Src gene was different between treated group and control. The results suggest that Src inhibition may be a useful drug target for angiogenesis suppression.

Keywords:

Angiogenesis; VEGFR1; c-Src; Cancer

Perma Link

https://www.civilica.com/Paper-CIGS15-CIGS15_067.html
COI code: CIGS15_067

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Bejary, Maedeh; Soheila Talesh Sasani & S Mohsen Asghari, 2018, Study of c-Src gene expression in response to an anti-angiogenesis peptide in breast cancer mice, The Third International and 15th National Genetics Congress, تهران, انجمن علمي ژنتيك ايران, https://www.civilica.com/Paper-CIGS15-CIGS15_067.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Bejary, Maedeh; Soheila Talesh Sasani & S Mohsen Asghari, 2018)
Second and more: (Bejary; Talesh Sasani & Asghari, 2018)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: state university
Paper No.: 11477
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.